Clinical trial
Beijing 302 Hospital
NCT05273541 is registered in ClinicalTrials.gov with Beijing 302 Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Beijing 302 Hospital
- Lead sponsor
- Beijing 302 Hospital
- Phase
- Phase 1/2
- Overall status
- Unknown status
- Start date
- February 11, 2022
- Completion date
- July 30, 2023
- Enrollment
- 100 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
covid-19, patients with cancer, vaccine reaction